Meetings

More than 80 researchers, students and industry representatives from Canada, Japan, France, the United Arab Emirates, and the United States gathered in Montreal from July 28 to 31 for the 4th CEMDI-PAIMS Symposium, an international event focused on advancing data-driven materials design and discovery. 

Led by Professor Kulbir Ghuman of the Institut national de la recherche scientifique (INRS), holder of the Canada Research Chair in Computational Materials Design for Energy and Environmental Applications, the 2026 edition of the symposium was held on the campus of McGill University. 

Rapid land use changes across the Southeast United States are creating challenges for young and beginning farmers, family farm operations and the economies of rural communities.

To address this challenge, the University of Tennessee Institute of Agriculture (UTIA) and the Tennessee Farm Bureau Federation will host the inaugural Southeast Farm and Forest Land Summit on Monday, October 12, 2026, at the Tennessee Farm Bureau headquarters in Columbia, Tennessee.

ARDD 2026 has announced that Thomas Marron, AVP, Emerging Innovation and Strategic Growth at Eli Lilly, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.

Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.

ARDD 2026 has announced that Kevin Duffin, VP, Aging Research at Eli Lilly, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.

Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.

ARDD 2026 has announced that Ruth Gimeno, VP Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development at Eli Lilly, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.

Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.

Leading voices from across the aerospace industry and academia gathered in Florence, Italy for the panel titled "Engineering Innovation Enabling Scientific Research," examining how advances in engineering are unlocking new scientific missions and how ambitious science goals are, in turn, driving engineering breakthroughs.

The panel, moderated by Alison Nordt, Director of Space Sciences & Instrumentation at Lockheed Martin Space's Advanced Technology Center, brought together six panellists to discuss the evolving relationship between space science and systems engineering: Marius Anger (Aalto University), Jon Arenberg (Northrop Grumman), Mayra Montrose (L3Harris), Giampiero Di Paolo (Thales Alenia Space Italia), Steve Squyres (Blue Origin) and Eric Stallmer (Voyager).

The 46th COSPAR Scientific Assembly brought together experts from astronomy, the satellite industry, policy and law to examine one of the most important challenges arising from the rapid growth of activities in space: how to preserve dark and quiet skies while enabling satellite systems to continue delivering valuable services to society. The meeting was chaired by Marco Tavani.